Background-Collectrin is an orphan member of the renin-angiotensin system and is a homolog of angiotensin-converting enzyme 2, sharing ≈50% sequence identity. Unlike angiotensin-converting enzyme 2, collectrin lacks any catalytic domain. Collectrin has been shown to function as a chaperone of amino acid transporters. In rodents, the renal expression of collectrin is increased after subtotal nephrectomy and during high-salt feeding, raising the question of whether collectrin has any direct role in blood pressure regulation. Methods and Results-Using a susceptible genetic background, we demonstrate that deletion of collectrin results in hypertension, exaggerated salt sensitivity, and impaired pressure natriuresis. Collectrin knockout mice display impaired endothelium-dependent vasorelaxation that is associated with vascular remodeling, endothelial nitric oxide synthase uncoupling, decreased nitric oxide production, and increased superoxide generation. Treatment with Tempol, a superoxide scavenger, attenuates the augmented sodium sensitivity in collectrin knockout mice. We report for the first time that collectrin is expressed in endothelial cells. Furthermore, collectrin directly regulates l-arginine uptake and plasma membrane levels of CAT1 and y + LAT1 amino acid transporters in endothelial cells. Treatment with l-arginine modestly lowers blood pressure of collectrin knockout mice.
C ollectrin (Tmem27 or Nx-17) was first identified in a screen for genes that are upregulated during the hypertrophic phase after renal mass ablation, a model of chronic kidney disease. 1 The protein product is a 222-aa transmembrane glycoprotein that shares ≈50% sequence identity with angiotensin-converting enzyme 2. Unlike angiotensin-converting enzyme 2, collectrin lacks any catalytic domain. 2 Collectrin is highly conserved among species, sharing >80% identity between mice, rats, and humans. Collectrin has a discrete tissue distribution, with the highest expression levels in the proximal tubule and collecting duct of the adult kidney, followed by pancreatic B cells, liver, intestinal epithelial cells, and the retina. Taken together, these data suggest that collectrin has distinct effects specific to its tissue localization. In support, in vitro and in vivo studies reveal that collectrin is involved in insulin secretion 3 and islet mass in the pancreas. 4 In the kidney, we and others have demonstrated that deletion of collectrin results in severe generalized urinary amino acid wasting as a result of reduced expression of neutral and cationic amino acid transporters in the plasma membrane of the proximal tubule brush border. 5, 6 These studies illustrate a role for collectrin as a chaperone for amino acid transporters. The mechanism by which collectrin mediates amino acid transporter trafficking is thought to be its binding with the SNARE complex. In the pancreas, collectrin facilitates SNARE complex formation by interacting with snapin, a synaptosomal-associated protein. 3 In the collecting duct, collectrin interacts with snapin, SNAP-23, syntaxin-4, and VAMP-2. 7 As a member of the angiotensin-converting enzyme family, how collectrin is functionally integrated in the context of blood pressure (BP) regulation is not known. The collectrin gene is located on the X chromosome, where loci have been linked to hypertension in both humans and rats. 8, 9 The expression of collectrin in the kidney is upregulated after 5/6 nephrectomy 1 and during salt-sensitive hypertension, 7 but the cause or effect remains to be established. Interestingly, in rat models of salt-sensitive hypertension, loci on the X chromosome have also been linked to hypertension 10 and hypertensive nephrosclerosis. 11 Taken together, the evidence suggests that collectrin plays a role in BP regulation. We set out to determine the role of collectrin in BP homeostasis in normal-and high-salt states. On a mixed genetic background, we found no BP difference between collectrin knockout (KO) and wild-type (WT) mice. 7 Because of the possibility that the genetic background masks any BP effect commonly observed in many mouse models of cardiovascular disease and hypertension, we backcrossed the collectrin-null mutation on the 129S6 strain that is susceptible to the development of hypertension and salt sensitivity. 12, 13 Here, on the 129S6 background, we show that collectrin is a determining factor in the development of hypertension in conditions in which the l-arginine/nitric oxide (NO)/superoxide pathway is altered.
Methods

Animals
Mice deficient of collectrin were generated by homologous recombination in embryonic stem cells, as previously reported. 5 To generate the inbred 129S6 collectrin KO mouse line, the null mutation was backcrossed onto the 129S6 background for >14 generations. The collectrin gene is located on the X chromosome; thus, WT littermates cannot be obtained for female KOs. Therefore, only male KO mice and their WT littermates were used for all studies described here. Animals were bred and maintained under local and National Institutes of Health guidelines.
Radiotelemetric BP Monitoring In Vivo
With the exception of BP measurement after subtotal nephrectomy, all BPs were measured in conscious mice under unrestrained conditions by radiotelemetry. Radiotelemetric units were implanted as previously described. 14 
Measurement of Tissue Superoxide and NO Levels
For superoxide, the method was modified from previous studies. 15, 16 Briefly, Krebs-HEPES buffer (in mmol/L: 99.0 NaCl, 4.69 KCl, 1.2 MgSO 4 , 25.0 NaHCO 3 , 1.03 KHPO 4 , 5.6 D(+) glucose, 20 Na HEPES, 2.5 CaCl 2 , pH 7.2-7.4 with 1N HCl) was oxygenated for 15 minutes in a water bath at 37°C. A 3-to 5-mg piece of kidney cortical tissue was placed in oxygenated buffer and incubated for 30 minutes in the water bath at 37°C and then placed into 5-µmol/L Lucigenin (9,9'-Bis-N-methylacridinium nitrate, Sigma; M8010) solution prepared in Krebs-HEPES buffer for 5 minutes. Then, luminescence counts were taken 5 times for 1 minute each, averaged, and corrected for baseline (5 µmol/L Lucigenin in Krebs-HEPES buffer measured 5 times for 1 minute and averaged). Tissue was dried in the dry block at 60°C to 70°C overnight. Results are expressed as counts per 1 mg dry tissue. NO activity was measured by conversion of [ 3 H]arginine to [ 3 H]citrulline via an NO assay kit (R&D Systems), as previously described. 17
Endothelium-Dependent and -Independent Relaxation Assays
Vasoreactivity measurements were performed as previously described. 18 See the online-only Data Supplement for additional information.
Isolation of Mouse Pulmonary Endothelial Cells
Primary lung endothelial cells (ECs) were isolated as previously described 17 and were used for subsequent l-arginine uptake assay. Details are given in the online-only Data Supplement. [ 3 H]l-arginine uptake assay was performed following a previously published protocol. 19 ECs were grown in 24-well plates to near confluence, washed in Dulbecco PBS, and incubated in Na-free uptake buffer for 5 minutes at 37°C. Some of the wells were then incubated with 0.5 mL per well of either warmed 50 μmol/L l-arginine+100 nmol/L [ 3 H]l-arginine or warmed 20 mmol/L l-arginine+100 nmol/L [ 3 H]l-arginine for 1 minute. The wells were then washed 4 times with ice-cold Na-free uptake buffer, and the cells were solubilized in 0.5 mL 0.2% SDS and 0.2N NaOH. Two 0.2-mL aliquots were counted with a Beckman Coulter scintillation counter, and 5 mL Ultama Gold LLT scintillation fluid (Perkin-Elmer) and two 25-μL aliquots were assayed for protein concentration with the Pierce BCA Protein Assay Kit (Thermo Scientific).
[ 3 H]l-Arginine Uptake
Statistics
Data are expressed as mean±SE. Statistical calculations were done with commercially available software packages (Minitab, Inc. and NCSS). The Student t test was used for comparisons between 2 groups unless otherwise stated. Differences between matched samples were analyzed by a paired t test. ANOVA was performed to test for significant overall group differences when there were >2 groups. Endothelium-dependent and -independent relaxation assays were analyzed with GraphPad Prism software. Values of P<0.05 were considered statistically significant. P values were 2 sided. Given the nature of the study, there was no adjustment for multiple comparisons.
Results
Deletion of Collectrin Causes Hypertension, Augmented Salt Sensitivity, and Attenuated Pressure Natriuresis Response
By radiotelemetry monitoring, collectrin KO mice have normal diurnal variation ( Figure IA in the online-only Data Supplement) but significantly elevated systolic BP (SBP; Figure 1A ) and mean arterial pressure ( Figure IB in the online-only Data Supplement) during both light and dark cycles. The average SBP over a 14-day period at baseline (on normal-salt diet) was ≈ 9 mm Hg higher in collectrin KO mice ( Figure 1B ) and is associated with a significant increase in heart mass ( Figure 1A ) that correlates well with SBP ( Figure  IC in the online-only Data Supplement), suggesting increased pressure load inducing cardiac remodeling. Because the expression of collectrin is upregulated in rodent models of chronic kidney disease and salt-sensitive hypertension, we assessed the effect of collectrin on BP in these models. After subtotal nephrectomy, collectrin KO mice had significant mortality within 2 weeks ( Figure IIA in the online-only Data Supplement). However, after uninephrectomy, collectrin KO mice had normal survival but developed much more severe hypertension than WT mice ( Figure IIB in the online-only Data Supplement). We next determined the effect of collectrin October 15, 2013 on salt sensitivity by feeding mice a high-salt diet (HSD; 6% NaCl) for 2 weeks. Compared with WT mice, which displayed a ≈8-mm Hg increase in SBP from normal-salt diet to HSD, collectrin KO mice displayed ≈15-mm Hg increase in SBP ( Figure 1B ). In addition, collectrin KO mice had a significantly lower urinary sodium excretion by the third day (acute phase) of HSD ( Figure 1B ). There were no significant differences in food or NaCl consumption between the 2 groups. However, there was a transient increase in water intake and a trend for increased urine volume in collectrin KO mice on day 1 (Table) . These findings demonstrate an attenuated pressure natriuresis response in collectrin KO mice. The significant increase in BP in collectrin KO mice after HSD was also accompanied by evidence of end-organ damage, including increased cardiac fibrosis (Figure 2A ), glomerular mesangial hypercellularity, and thickened renal vascular walls ( Figure 2B ).
Deletion of Collectrin Results in Altered Balance of NO and Superoxide
To begin to understand the mechanism contributing to hypertension and salt sensitivity in collectrin KO mice, we examined whole-kidney plasma membrane expression of renal epithelial salt transporters and channels, including αENaC, NHE3, NKCC, Na-K-ATPase, and NaPi2, but found no differences ) and NO generation, respectively, during the first 3 days of HSD. Collectrin KO mice excreted more than twice the levels of 8-isoprostane F 2α and 40% less nitrates/nitrites compared with WT ( Figure 3A) . These data suggest that augmented renal O 2
• − generation or impaired renal NO production contributes to altered BP regulation and pressure natriuresis in collectrin KO mice.
Hypertension and salt sensitivity are pathological conditions commonly associated with a state of endothelial NO synthase (eNOS) uncoupling. [20] [21] [22] [23] In the active form, eNOS is a homodimer that oxidizes l-arginine to l-citrulline and NO. Various perturbations, including decreased availability of l-arginine, can lead to the uncoupling of eNOS to the monomeric form that generates O 2
• − instead of NO. 24, 25 We next compared baseline levels of eNOS dimer and monomer in the aorta and kidney cortex and medulla. In these tissues, eNOS dimer and dimer/monomer ratios were significantly lower in collectrin KO mice compared with WT ( Figure 3B ), suggesting that there is an altered balance of active and inactive eNOS in collectrin KO mice that favors a state of increased O 2
• − generation and reduced NO synthesis. In support, we found a significant increase in baseline O 2
• − and a significant decrease in baseline NO levels in whole-kidney tissues in KO mice ( Figure 3C ). We next determined whether the superoxide scavenger Tempol would correct the augmented sodium sensitivity in collectrin KO mice. Treatment with Tempol (via osmotic pump) resulted in a mild but statistically insignificant lowering of BP in both WT and KO mice at baseline. Tempol did not attenuate salt sensitivity in WT mice. However, Tempol significantly attenuated the increase in BP in collectrin KO during high-salt feeding ( Figure 3D ), resulting in a similar change in BP from normal salt to high salt between WT and KO mice ( Figure 3E ). These data suggest that the mechanism for augmented sodium sensitivity in collectrin KO mice is mediated in part by superoxide.
Loss of Collectrin Causes Impairment in Endothelium-Dependent Vasorelaxation
The expression of collectrin in ECs has not been previously reported. Here, we show that collectrin is expressed in ECs in We next queried whether loss of collectrin could lead to endothelial dysfunction, and we compared the resistance vessel relaxation capacity of third-order mesenteric arteries between WT and KO mice fed a normal-salt diet. Collectrin KO mice have severely impaired endothelium-dependent relaxation of third-order mesenteric arteries in response to acetylcholine ( Figure 4F ). Very similar differences in response to acetylcholine were also observed in thoracodorsal arteries between the 2 groups ( Figure 4F ). Transmission electron microscopy revealed that the thoracodorsal arteries of collectrin KO mice are markedly remodeled, with vacuolization of ECs and a hypertrophic and disorganized smooth muscle layer ( Figure 4G ). To determine whether the vascular smooth muscle cells play a role in the impaired vasorelaxation in collectrin KO mice, we performed an endothelium-independent relaxation assay using sodium nitroprusside. As shown in Figure 4H , WT and collectrin KO mesenteric and thoracodorsal arteries had virtually identical vasodilatory responses to sodium nitroprusside, suggesting that the impaired vasodilation in the collectrin KO mice is primarily dependent on the endothelium.
Collectrin Regulates l-Arginine Uptake and Plasma Membrane Expression of l-Arginine Amino Acid Transporters in ECs
Our data raise the central question of whether collectrin regulates BP through its role in amino acid transport, particularly l-arginine. In this regard, KO mice have altered BP homeostasis, which is associated with abnormal NO synthesis and O 2
• − generation. In several cell types, including the ECs and renal epithelium, the synthesis of NO requires the de novo import of extracellular l-arginine. [26] [27] [28] l-Arginine transport into cells is mediated by different classes of amino acid transporters that are defined by their ion dependency, substrate specificity, and relative affinity. 29, 30 In ECs, system y + , a sodium-independent system, accounts for ≈60% of l-arginine transport, and system y + L, a sodium-dependent system, accounts for ≈40% of l-arginine transport. 26, 31, 32 System y + selectively mediates the cellular transport and exchange of cationic amino acids, including l-arginine, whereas system y + L transports and mediates the exchange of both cationic and neutral amino acids. 26, 28 Endothelium-dependent relaxation has been shown to be impaired in a patient with l-arginine deficiency who was shown to be a compound heterozygote for 2 mutations in the SLC7A7 gene that encodes for the y + LAT1 amino acid transporter. The patient's endothelium-dependent relaxation was corrected with l-arginine infusion. 33 Thus, a defect in l-arginine uptake may lead to endothelial dysfunction. To determine whether collectrin-deficient ECs have impaired l-arginine uptake, we isolated primary ECs from WT and collectrin KO mice from the pulmonary artery using fluorescence-activated cell sorting. 17 Collectrin KO ECs display significantly lower [ 3 H]l-arginine uptake than WT ECs ( Figure 5A ). To rule out the possibility that altered structural integrity of collectrindeficient ECs ( Figure 4G ) influenced l-arginine uptake and to demonstrate a direct cause and effect of collectrin on l-arginine uptake, we used a primary human coronary EC line and successfully overexpressed collectrin ( Figure 5B ). Human coronary ECs overexpressing collectrin have significantly higher levels of [ 3 H]l-arginine uptake compared with control cells ( Figure 5B ). We previously reported that collectrin KO mice have generalized urinary amino acid wasting and decreased protein expression of the apical amino acid transporters in plasma membrane fractions of the renal proximal tubules, suggesting that collectrin is a chaperone that mediates the trafficking of amino acid transporters to the plasma membrane. 5 We next examined whether collectrin affects the expression of the y + (CAT1) and y + L (y + LAT1) amino acid transporter systems that are known to regulate l-arginine transport in ECs. 34 We demonstrate that knockdown of collectrin results in a significant decrease in expression of CAT1 and y + LAT1 transporters in human coronary EC plasma membrane fractions and decreased eNOS dimerization ( Figure 5C ). Conversely, overexpression of collectrin significantly increases the expression levels of these transporters and increases eNOS dimerization Figure 5D ). We also examined whether loss of collectrin also affects kidney plasma membrane expression of the y + LAT1 transporter that is localized to the basolateral membrane in renal epithelial cells. 35 We found a significant decrease in the expression of the y + LAT1 transporter in whole-kidney plasma membrane fractions from KO mice ( Figure IV in the onlineonly Data Supplement). We next queried whether supplementation with l-arginine would ameliorate or decrease BP in collectrin KO mice. We administered l-arginine in drinking water (50 mg•kg −1 •d −1 ). As demonstrated in Figure 5E , by the end of 1 week of treatment with l-arginine, a modest but significant decrease in SBP in collectrin KO mice was observed.
There was no further decrease in SBP beyond 1 week of l-arginine treatment.
Discussion
Collectrin is an "orphan" member of the renin-angiotensin system with a previously unrecognized role in cardiovascular and renal physiology. We demonstrate that loss of collectrin results in hypertension, altered pressure natriuresis, and superoxide-dependent augmented salt sensitivity. We further demonstrate that deletion of collectrin results in endothelial dysfunction, which is associated with eNOS uncoupling, increased O 2 • − production, and decreased NO availability, likely as a result of impaired cellular uptake of l-arginine substrate. Our data suggest that collectrin plays a protective role against conditions that predispose to the hypertensive state by maintaining a balance of NO and O 2
• − through its role in facilitating the cellular uptake of l-arginine. It is worth noting that we previously reported that collectrin KO mice have normal development, are able to compensate for renal wasting of amino acids by increased liver synthesis of nonessential amino acids, and are able to maintain normal serum levels of all amino acids, including l-arginine. 5, 36 Thus, the effect of collectrin deficiency on BP is unlikely from renal wasting of l-arginine per se. Our data suggest that collectrin may regulate BP specifically through its role chaperoning l-arginine transporters expressed in ECs and possibly in renal epithelial cells for the intracellular uptake of l-arginine. The partial BP lowering response to l-arginine infusion supports the notion of competitive inhibition of l-arginine uptake by other extracellular cationic amino acids such as lysine. 28 Accordingly, administration of l-arginine could overwhelm the competitive inhibition of extracellular lysine. However, the lack of normalization of BP by l-arginine infusion implicates a severe deficit in the functional activity of the CAT1 and y + L system transporters resulting from their diminished plasma membrane expression. It is also possible that collectrin interacts with other machinery that regulates eNOS enzymatic activity. In this regard, endothelial caveolae containing caveolins are important in determining intracellular localization of eNOS and enzymatic activity. 37 Interestingly, endothelial caveolae contain some members of the SNARE complex 38 with which collectrin interacts. 3, 7 Our study suggests that the altered balance of NO and O 2 • − plays a partial role in the elevation of BP and augmented sodium sensitivity in collectrin KO mice. It is likely that other yet-to-be-determined mechanisms are also involved.
Our findings are consistent with the clinical observation that mutations resulting in dysfunction of the y + LAT1 transporter cause impaired endothelium-dependent relaxation. 33 The reduction in l-arginine transport via the y + L system has also been observed in hypertension in both humans and animals. 39, 40 In addition, the Dahl salt-sensitive versus salt-resistant rats are a classic genetic model that links salt-sensitive hypertension with alteration in the O 2
• − /NO states. Dahl saltsensitive rats consuming an HSD exhibit increased urinary excretion of 8-isoprostane, an index of oxidative stress, and significant reductions of kidney and aorta eNOS. 41 Infusion of l-arginine into the renal medullary interstitium of Dahl salt-sensitive rats prevents the development of hypertension during high-salt feeding. 42 The genetic basis for their phenotype is unclear. Our studies demonstrate that collectrin-deficient mice have a phenotype very similar to that of the Dahl salt-sensitive rats.
Although an 8-to 9-mm Hg baseline increase in SBP in collectrin KO may be viewed as modest, it is worth noting that this has significant physiological effects because collectrin KO mice have increased heart mass and vascular remodeling at baseline. Results from numerous clinical trials show that even a 2-to 3-mm Hg increase in SBP confers a significant increase in cardiovascular disease risks. In addition, collectrin KO mice on an HSD have a ≈15-mm Hg higher SBP than WT mice on an HSD, along with increased cardiac fibrosis and mesangial hypercellularity in the glomerulus. This augmented sodium sensitivity is mediated in part by superoxide.
As mentioned, our previous study using mice on a mixed genetic background showed that collectrin KO mice have a basal BP similar to that of WT mice, and they did not exhibit sodium sensitivity. 7 This demonstrates that the role of collectrin on BP regulation in normal and pathophysiologic states is dependent on the genetic background. The dependency on a susceptible genetic milieu is similar to many rodent models of human diseases. For example, the Ace2 and the frequently used Apoe KO mouse models require the C57BL/6 strain for the development of hypertension 14 and abdominal aortic atherosclerotic disease, 43, 44 respectively. The requirement of a proper genetic background does not diminish the significance of the effect of a gene but highlights the involvement of epigenetic or multigenic effects. In essential or saltsensitive hypertension, the pathogenesis is likely mediated by small effects of many genes rather than a rare large effect of 1 single gene.
It is worth noting that our studies were conducted with male mice because collectrin is on the X chromosome and therefore WT littermates cannot be obtained for female KO mice. It remains to be determined whether collectrin has the same effect on BP and salt-sensitive hypertension in female mice. Interestingly, in the Sabra rat model of salt-sensitive hypertension, loci on the X chromosome have also been linked to salt sensitivity in females but not in males. 10 discrepancy of the position of the rat microsatellite markers, which differ significantly between 2003 and 2012, it is unclear whether collectrin lies within any of these loci. In humans, it is not known whether there are any loci on the X chromosome that contribute to sex-linked differences in heritability of hypertension because until recently genome-wide association studies largely excluded X chromosome variants from analyses. Although our results may suggest that the endothelial dysfunction in collectrin KO mice could contribute to their hypertension, they are interpreted with caution because impairment in endothelial function may also be a consequence of hypertension that induces remodeling of the endothelium. We cannot rule out possible effects of collectrin on circulating or other vasoactive mediators released by the endothelium such as endothelium-derived hyperpolarizing factor, prostacyclin, and epoxyeicosatrienoic acids. Endothelium-specific deletion of collectrin will provide direct proof of causality and will be a focus of future studies.
Our studies raise the key question of which specific collectrin-expressing cell plays a major role in BP regulation. Guyton and Coleman 45 advanced the paradigm that the substantial capacity of the kidney for sodium excretion provides a compensatory system of virtually infinite gain to oppose processes causing elevation in BP, including increases in peripheral vascular resistance. It follows that in collectrin KO mice, even if the initial cause of hypertension is increased peripheral vascular resistance from reduced vasorelaxation, a defect in renal excretory function would be a prerequisite for the sustained chronic increase in BP. The altered pressure natriuresis observed in collectrin KO mice suggests that the altered kidney function could result from a defect in renal epithelial function or renal hemodynamics. We found no alteration in the expression of renal epithelial sodium transporters or channels in the kidney in collectrin KO mice at baseline, but we cannot exclude improper localization of these transporters or channels. We postulate that the impaired pressure natriuresis is due, at least in part, to abnormal regulation of renal vascular resistance, 46 possibly caused by a deficiency in NO. 47, 48 These possibilities will be a major focus in future studies. Collectrin is also expressed in the basolateral surface of the collecting duct epithelium (Zhang et al 1 and our unpublished data), where neuronal NOS is localized and has been shown to be the source of NO that mediates medullary blood flow 49 and natriuresis. 50 Whether collectrin affects the dimerization and function of neuronal NOS in the collecting duct remains to be explored. Ultimately, it will be necessary to determine the precise cell lineage-in the kidney (and in which compartment: vascular versus proximal tubule, collecting duct epithelium, or both), outside the kidney, or both-in which BP is regulated by the actions of collectrin.
Conclusions
Our studies have unveiled collectrin as a determining factor in the development of hypertension in conditions in which the l-arginine/NO/O 2 • − pathway is altered. Loss of collectrin function may also affect other physiological and pathophysiological states that are influenced by NO or superoxide signaling.
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SUPPLEMENTAL MATERIAL
Supplemental Experimental Procedures
Radiotelemetric blood pressure monitoring in vivo. Briefly, mice were anesthetized with 2% isoflurane in medical oxygen (95% O 2 and 5% CO 2 ). A catheter and sensor (TA11PA-C10, Data Sciences International (DSI), St. Paul, MN) was implanted in the left carotid artery, and the radiotransmitter was placed in a subcutaneous pouch along the flank. A post-operative analgesic, buprenorphine, 0.1 mg/kg body weight, sc., and 0.25% bupivacaine, 0.02-0.05 mg/kg, sc., was given to relieve pain. Mice were allowed to recover for 7 days after surgery to regain their normal circadian rhythms before blood pressure measurements and experiments were initiated. While blood pressure was being monitored, mice were housed in a quiet room in individual cages placed above the telemetric receivers with an output to a computer. Blood pressures were collected every 1 hour for 5 minutes, processed, and analyzed using Dataquest Renal Ablation: Under general anesthesia, (1.5 % isoflurane), the right kidney was removed (for both sub-total nephrectomy or uni-nephrectomy), and the blood supply of the upper half of the left kidney was interrupted by ligation of the upper branch of the two main branches of the left renal artery (for sub-total nephrectomy) as previously reported (1) .
Measurement of blood pressure using tail cuff manometry.
Blood pressures in mice subjected to nephrectomy were measured using a computerized tail cuff system (Hatteras Instruments, Cary NC) that determines tail blood flow using a photoelectric sensor. This system allows for blood pressures to be measured in four mice simultaneously and minimizes the potential for observer bias. Mice are trained for blood pressure measurement everyday for 2 weeks, then systolic blood pressures are recorded daily for 2 weeks. Endothelium-dependent and -independent relaxation assays. Vasoreactivity measurements were performed as previously described (3) . Mice were sacrificed with CO 2 and both thoracodorsal (TD) arteries and the whole mesentery were isolated and placed in Kreb's Hepes solution or MOPS buffer respectively. The TD and 3rd order mesenteric arteries were free of surrounding tissue and cannulated at both ends on glass micropipettes, secured with a 10-0 nylon monofilament suture in a pressure myograph (Danish MyoTechnology, DMT). The TD and 3rd order mesenteric arteries were maintained at 37°C in a no-flow state and held at a constant transmural pressure of 80 mmHg and 75mmHg respectively (3) (4) . TD arteries and mesenteric arteries were pre-constricted with phenylephrine (PE, 10 µM), respectively and the internal diameter was measured in response to cumulative concentrations of Ach or SNP (10 -9 to 10 -3 M). Vessel diameter was quantified after each dose of Ach or SNP using the slide book software or the DMT vessel acquisition software as previously described (3, 5) .
Measurement
Isolation of mouse pulmonary endothelial cells. Primary lung endothelial cells were isolated
as previously described (6) The primary antibody against collectrin was obtained as described above, and against CD105 (Biolegend) specific for endothelial cells). After rinsing with 0.1% BSA, 0.2% gelatin, and 0.05% saponin in PBS, the sections were reacted 1 hr with secondary antibody diluted in 0.1% BSA and 0.3% Triton X-100 in PBS. The secondary donkey anti-rabbit antibodies used were Alexa555-or Alexa647-conjugated (Invitrogen Corp., Carlsbad, CA). After washes with PBS, the sections were mounted in Vectashield solution containing DAPI to stain nuclei (H-1500, Vector Labs., Burlingame, CA). Confocal fluorescence images were taken using a Zeiss LSM 510 microscope and software (Carl Zeiss MicroImaging, Inc., Thornwood, NY). 
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